Status:
UNKNOWN
Vascular Abnormalities Detected With Chest CT in COVID-19
Lead Sponsor:
Salah D. Qanadli
Collaborating Sponsors:
University of Geneva, Switzerland
University of Bern
Conditions:
Covid19
Pneumonia, Viral
Eligibility:
All Genders
18+ years
Brief Summary
Chest computed tomography of patients having coronavirus disease (COVID-19) will be analyzed with regards to vascular abnormalities (pulmonary embolism and vascular thickening), and their association ...
Detailed Description
Since the SARS-CoV-2 outbreak, computed tomography (CT) imaging has almost immediately established itself as the primary non-invasive diagnostic tool for diagnosis, monitoring of COVID-19 pneumonia, a...
Eligibility Criteria
Inclusion
- Patients admitted for COVID-19 (with positive rt-PCR for SARS-CoV-2) who had a contrast-enhanced chest CT within the specified timeframe.
Exclusion
- Age \<18 years Patients with another pre-existing infectious process Documented refusal of the reuse of medical data
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04824313
Start Date
March 1 2020
End Date
March 31 2021
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUV
Lausanne, Canton of Vaud, Switzerland, 1011